Clinical and Diagnostic Platforms


i3S houses two clinical and diagnostic platforms:




Not only are these clinical initiatives central to attend to specific needs of patients, but they are also a sort of test tube to some of the research developed in our laboratories. They are an integral part of i3S and are crucial to close the cycle of innovation we propose to achieve and already in motion. In fact, i3S contributes to and integrates the regional strategy, namely by establishing partnerships with the neighboring community and other relevant actors in the health sector. Besides working towards unraveling disease mechanisms and coming up with novel therapeutic solutions, we increasingly handle the business side by bridging the gap that often separates breakthrough research and industry.

At the same time, i3S maintains a strong connection to the largest hospitals in the Northern region, namely CH S. João, CH Porto and IPO, turning our institute into a leading player when it comes to the consolidation of Northern Portugal’s health cluster. Porto Comprehensive Cancer Center is the crystallization of such significant collaborative relationships, and a reciprocal boost to place the involved institutions in the forefront of European research in health.